ÃâÒßѧÊÔÌâ
fg[]>:ZT. Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
x !)[l; 1. Fas(CD95)/FasL
_
4!SO5T 2. common chain of cytokine receptor
J})#43P 3 . TCR/CD3 complex
Z]Zs"$q@ 4. negaive selection of thymocytes
Ojea~Y]Sr 5. artificial active immune
SM3qPlsF 6. anti-idiotypic
{3V% 7. IgSF
?U}Ml]0~ 8. Integrin
f
Dq`.ZW)s 9. chemokine
t,
CC~ 10. B7/CD28
<4DSk9/ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
kTCWyc 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
R9dC$Y]\M 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
:Fv
d?[ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
;c>Co:W 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
0u,OW
EUVB>%P 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
="M7F0k µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
naQ0TN, Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
R
78=im7 1. B7/CD28
n_8wYiBs( 2. Th1 subset
rSGt`#E-s. 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
HOEjLwH 4. antibody affinity maturation
!a(#G7zA 5. AP-1
dcK7Dd-> 6. single chain variable fragment£¨ScFv£©
s:4<wmu4= 7. NK cell receptor
VaLx- RX 8. Zinkernagel-Doherty phenomenon
jjs1Vj1@< 9. Ig fold
.H.#W1` 10. CD40/CD40L
2f;fdzjk8K ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
d|nJp-%V 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
D$
>gAv 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
I eQF+Xz 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
EPY64{ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
.6@qU} 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
!jV}sp<Xp 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
AbWnDqv 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
;bC163[ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
wEMh !jAbv £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
[c{/0* Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
%*>ee[^L , 1.Co-stimulators (or co-stimulating molecules)
G! y~Y]e 2.NK-kB
3C=| 3.Immunoglobulin superfamily
xz@/^Cj 4.antigen-presenting cell (APC)
j'z}m+_? 5.death domain
z[7j`J|Kk 6.CCR and CXCR
S\qYw(G
7.Lectin (or mitogen)
~AD%aHR 8.Clusters of differentiation, CD)
,ZVC@P,L 9.B7 family
t-xw=&!w 10.Cytotoxic T lymphocyte, CTL)
QQ+? J~ 11.IL-15 and IL-15 receptor (IL-15R)
R\L0 12.MHC restriction
CB<i 13.Affinity-chromatography
R'#[}s 14.Cyctosprin A, CsA
+) pO82 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
rPK)=[MZ ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
L*A9a 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
8s,B,s. 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
ZDmBuf
q 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
g3p*OYf Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
N2!HkUy2 ÃâÒßѧרҵ£º
cU,]^/0Y 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
RCFocOOn Ïû»¯ÄÚ¿Æ£º
63ig!-9F 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
.A: #l? ѪҺ²¡Ñ§×¨Òµ£º
=Q % F~ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
L*2YA
IG Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
w7.I0)MH (רҵ»ù´¡: ÃâÒßѧ)
&_q&TEi Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
93zoJiLRf 1. ADCC(antibody dependent cell-mediated cytotoxicity)
&zl=}xeA 2. »·æß¾úËØ(cyclosporin)
.%{3#
\ 3. KIR(killer cell inhibitory receptor)
Kh)SgJ3B@ 4. HLDA(human leucocyte differentiation antigen)
[m>kOv6>^ 5. Interleukin 18(IL-18)
.xRJ )9q 6. ÕûºÏËØ(integrin)
[4V{~`sF 7. Fas/FasL
b)+;#m 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
g]^@bxdg 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
7*bUy)UZ 10. Th1/Th2
jhd&\z- 11. »ùÒòÒßÃç(DNAÒßÃç)
mnKSO 12. chemokines and chemokine receptor
W^}fAcQKH 13. ÃâÒßÄÍÊÜ
WoP5[.G 14. ¹²´Ì¼¤·Ö×Ó
Wb*A};wE 15. ËÀÍö½á¹¹Óò(death domain)
D0 'L ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
_#6_7=g@s6 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
+RXKI{0Km 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
LvlVZjT £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
4Wz@^7|V5 £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
fi5x0El
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
OhC%5=a7 £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
-+^E5 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
^Ht!~So Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
MeD}S@H ÎÊ´ðÌâ(ÿÌâ25·Ö)
gi26Dtk(h 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
lX^yd5M&f 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
y|sU-O2}Dl 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
AfU~k!4` 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£